Genomic Determinants of Resistance to Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) Therapies in Patients with Relapsed/Refractory Multiple MyelomaFrancesco Maura, Kenneth H. Shain, Holly Lee et al.|Blood|2024Cited by 9